NCT05874674 The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
| NCT ID | NCT05874674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wonju Severance Christian Hospital |
| Condition | Dialysis; Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-12-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparison nafamostat and low molecular weight heparin among dialysis patients
Eligibility Criteria
Inclusion Criteria: * platelet below 10k PTT above 60 second INR above 20 patient with bleeding (epistaxis, orbital bleeding, hematuria) recent brain hemorrhage (within 6 months) receiving anticoagulant therapy (coumadin or NOAC) dual antiplatelet agent users received major surgery within one month Exclusion Criteria: * cancer liver cirrhosis pregnancy drug allergy current bleeding on major organ (brain, gastrointestinal)
Frequently Asked Questions
Who can join the NCT05874674 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Dialysis; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05874674 currently recruiting?
Yes, NCT05874674 is actively recruiting participants. Visit ClinicalTrials.gov or contact Wonju Severance Christian Hospital to inquire about joining.
Where is the NCT05874674 trial being conducted?
This trial is being conducted at Wŏnju, South Korea.
Who is sponsoring the NCT05874674 clinical trial?
NCT05874674 is sponsored by Wonju Severance Christian Hospital. The trial plans to enroll 100 participants.